Manganese superoxide dismutase polymorphism and risk of gastric lesions, and its effects on chemoprevention in a chinese population

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 4, 2010, Pages 1089-1097

  Tu, Hua Kang ^a,b   Pan, Kai Feng ^b   Zhang, Yang ^b   Li, Wen Qing ^b   Zhang, Lian ^c   Ma, Jun Ling ^b   Li, Ji You ^c   You, Wei Cheng ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; IMMUNOGLOBULIN G; MANGANESE SUPEROXIDE DISMUTASE; VALINE;

ADULT; ARTICLE; DNA POLYMORPHISM; DYSPLASIA; FEMALE; GENOTYPE; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH CANCER; STOMACH LESION; VITAMIN SUPPLEMENTATION;

ADULT; ASCORBIC ACID; ASIAN CONTINENTAL ANCESTRY GROUP; DIETARY SUPPLEMENTS; FEMALE; GARLIC; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECANCEROUS CONDITIONS; SELENIUM; STOMACH NEOPLASMS; SUPEROXIDE DISMUTASE; VITAMIN E; VITAMINS;

EID: 77950823539     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-1174     Document Type: Article

References (45)

1. Cerutti PA. Prooxidant states and tumor promotion. Science 1985; 227:375-381
2. Ambrosone CB, Freudenheim JL, Thompson PA, et al. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res 1999; 59:602-6.
3. von SC, Schuchmann HP. Radical-mediated DNA damage in presence of oxygen. Methods Enzymol 1990;186:511-520
4. 4. Kinnula VL, Crapo JD. Superoxide dismutases in malignant cells and human tumors. Free Radio Biol Med 2004;36:718-744 (Pubitemid 38264416)
5. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, NakagawaHattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun 1996;226:561-565
6. 6. Sutton A, Khoury H, Prip-Buus C, Cepanec C, Pessayre D, Degoul F. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 2003;13:145-157 (Pubitemid 36324244)
7. Murphy SJ, Hughes AE, Patterson CC, et al. A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett's esophagus and esophageal adenocarcinoma. Carcinogenesis 2007; 28:1323-1328
8. 8. Hung RJ, Boffetta P, Brennan P, et al. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis 2004;25:973-978 (Pubitemid 38886083)
9. 9. Martin RC, Lan Q, Hughes K, et al. No apparent association between genetic polymorphisms (-102 C > T) and (-9 T > C) in the human manganese superoxide dismutase gene and gastric cancer. J Surg Res 2005;124:92-97 (Pubitemid 40269807)
10. 10. Landi S, Gemignani F, Neri M, et al. Polymorphisms of glutathione-Stransferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma. Int J Cancer 2007;120:2739-2743 (Pubitemid 46651299)
11. Bag A, Bag N. Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: a review. Cancer Epidemiol Biomarkers Prev 2008;17:3298-3305
12. 12. Li H, Kantoff PW, Giovannucci E, et al. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res 2005;65:2498-2504 (Pubitemid 40490163)
13. 13. You WC, Blot WJ, Li JY, et al. Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res 1993;53:1317-1321 (Pubitemid 23097109)
14. 14. You WC, Zhang L, Gail MH, et al. Precancerous lesions in two counties of China with contrasting gastric cancer risk. Int J Epidemiol 1998;27:945-948 (Pubitemid 29026742)
15. Zhang L, Blot WJ, You WC, et al. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population. Cancer Epidemiol Biomarkers Prev 1996;5:627-630
16. Kneller RW, You WC, Chang YS, et al. Cigarette smoking and other risk factors for progression of precancerous stomach lesions. J Natl Cancer Inst 1992;84:1261-1266
17. 17. Zhang L, Blot WJ, You WC, et al. Serum micronutrients in relation to pre-cancerous gastric lesions. Int J Cancer 1994;56:650-654 (Pubitemid 24086766)
18. You WC, Blot WJ, Chang YS, et al. Diet and high risk of stomach cancer in Shandong, China. Cancer Res 1988;48:3518-3523
19. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169-1179
20. 20. You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 2006;98:974-983 (Pubitemid 44288162)
21. Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985;64:111-126
22. Davies GR, Simmonds NJ, Stevens TR, et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994;35:179-185
23. Davies GR, Banatvala N, Collins CE, et al. Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scand J Gastroenterol 1994;29:419-424
24. Farinati F, Della LG, Cardin R, et al. Gastric antioxidant, nitrites, and mucosal lipoperoxidation in chronic gastritis and Helicobacter pylori infection. J Clin Gastroenterol 1996;22:275-281
25. Baik SC, Youn HS, Chung MH, et al. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res 1996;56:1279-1282
26. Albano E. Alcohol. Oxidative stress and free radical damage. Proc Nutr Soc 2006;65:278-290
27. Gail MH, You WC, Chang YS, et al. Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data. Control Clin Trials 1998;19:352-369
28. You WC, Li JY, Blot WJ, et al. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer 1999;83:615-619
29. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 2002;33:337-349
30. 58Thr reduces activity by destabilizing the tetrameric interface. BiochemistryUs 1996;35:4287-4297
31. 31. Xu Y, Krishnan A, Wan XS, et al. Mutations in the promoter reveal a cause for the reduced expression of the human manganese superoxide dismutase gene in cancer cells. Oncogene 1999;18:93-102. (Pubitemid 29060583)
32. Mikhak B, Hunter DJ, Spiegelman D, et al. Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk. Carcinogenesis 2008;29:2335-2340
33. 33. Mitrunen K, Sillanpaa P, Kataja V, et al. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis 2001;22:827-829 (Pubitemid 32447933)
34. Cooper ML, Adami HO, Gronberg H, Wiklund F, Green FR, Rayman MP. Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk. Cancer Res 2008;68:10171-10177
35. Fridovich I. Biological effects of the superoxide radical. Arch Biochem Biophys 1986;247:1-11.
36. 2. Antioxid Redox Signal 2006;8: 1295-1305
37. Kamata H, Hirata H. Redox regulation of cellular signalling. Cell Signal 1999;11:1-14.
38. You WC, Zhang L, Gail MH, et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst 2000;92:1607-1612
39. Danese S, Cremonini F, Armuzzi A, et al. Helicobacter pylori CagApositive strains affect oxygen free radicals generation by gastric mucosa. Scand J Gastroenterol 2001;36:247-250
40. Ando T, Perez-Perez Gl, Kusugami K, Ohsuga M, Bloch KC, Blaser MJ. Anti-CagA immunoglobulin G responses correlate with interleukin8 induction in human gastric mucosal biopsy culture. Clin Diagn Lab Immunol 2000;7:803-809
41. Kreuning J, Lindeman J, Biemond I, Lamers CB. Relation between IgG and IgA antibody titres against Helicobacter pylori in serum and severity of gastritis in asymptomatic subjects. J Clin Pathol 1994;47:227-231
42. Perez-Perez Gl, Brown WR, Cover TL, Dunn BE, Cao P, Blaser MJ. Correlation between serological and mucosal inflammatory responses to Helicobacter pylori. Clin Diagn Lab Immunol 1994;1:325-329
43. Kolho KL, Karttunen R, Heikkila P, Lindahl H, Rautelin H. Gastric inflammation is enhanced in children with CagA-positive Helicobacter pylori infection. Pediatr Infect Dis J 1999;18:337-341
44. 44. Farinati F, Cardin R, Degan P, et al. Oxidative DNA damage accumulation in gastric carcinogenesis. Gut 1998;42:351-356 (Pubitemid 28197023)
45. Woodson K, Tangrea JA, Lehman TA, et al. Manganese superoxide dismutase (MnSOD) polymorphism, α-tocopherol supplementation and prostate cancer risk in the α-tocopherol, β-carotene cancer prevention study (Finland). Cancer Causes Control 2003;14:513-518